{"id":"https://openalex.org/W950313653","doi":null,"title":"Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of HIV-1","display_name":"Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of HIV-1","publication_year":2014,"publication_date":"2014-11-28","ids":{"openalex":"https://openalex.org/W950313653","mag":"950313653"},"language":"en","primary_location":{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1455362","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1455362/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Doctoral thesis, UCL (University College London).","raw_type":"Thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058769381","display_name":"Katherine A. Sutherland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Katherine A. Sutherland","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5058769381"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.8230000138282776},{"id":"https://openalex.org/keywords/gag","display_name":"Gag","score":0.7639999985694885},{"id":"https://openalex.org/keywords/hiv-1-protease","display_name":"HIV-1 protease","score":0.8790000081062317},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.8510000109672546},{"id":"https://openalex.org/keywords/atazanavir","display_name":"atazanavir","score":0.7950000166893005},{"id":"https://openalex.org/keywords/subtype-b","display_name":"subtype B","score":0.5149999856948853},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.9729999899864197},{"id":"https://openalex.org/keywords/protease-substrates","display_name":"protease substrates","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.8598840832710266},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5594345927238464},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5077899098396301},{"id":"https://openalex.org/C2777583353","wikidata":"https://www.wikidata.org/wiki/Q410261","display_name":"HIV-1 protease","level":4,"score":0.5003128051757812},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.4283086061477661},{"id":"https://openalex.org/C106358424","wikidata":"https://www.wikidata.org/wiki/Q1662346","display_name":"Infectivity","level":3,"score":0.4280676245689392},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.4245935082435608},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3930862545967102},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3300377130508423},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.24832284450531006},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.1614716351032257},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.13965323567390442},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10155150294303894},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.05624544620513916}],"mesh":[],"locations_count":4,"locations":[{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1455362","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1455362/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Doctoral thesis, UCL (University College London).","raw_type":"Thesis"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1455524","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1455524/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Doctoral thesis, UCL.","raw_type":"Thesis"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1455525","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1455525/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Doctoral thesis, UCL.","raw_type":"Thesis"},{"id":"mag:950313653","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1455362/","pdf_url":null,"source":{"id":"https://openalex.org/S4306508231","display_name":"Doctoral thesis, UCL (University College London).","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Doctoral thesis, UCL (University College London).","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2110205377","https://openalex.org/W3128148111","https://openalex.org/W2049673515","https://openalex.org/W2260178647","https://openalex.org/W2559271924","https://openalex.org/W2089479036","https://openalex.org/W396729771","https://openalex.org/W3097197480","https://openalex.org/W2063726962","https://openalex.org/W2161967914"],"abstract_inverted_index":{"Recent":[0],"reports":[1],"have":[2],"shown":[3,158,197],"that":[4,276],"HIV-1":[5],"Gag":[6,27,54,103,112,254,266],"can":[7,35],"directly":[8],"affect":[9],"susceptibility":[10,33,38,64,180,204,212,229,279],"to":[11,41,90,106,127,131,135,159,161,193,284],"protease":[12,29,42,114,139,151,245,268],"inhibitors":[13],"(PIs)":[14],"in":[15,22,30,39,62,93,110,123,150,164,167,178,227,248,255],"the":[16,107,136,141,145,168,199,239,244,250,261],"absence":[17,169],"of":[18,25,68,144,170,176,190,201,230,238,242,253,263],"known":[19],"resistance":[20,172],"mutations":[21],"protease.":[23],"Inclusion":[24],"co-evolved":[26,265],"alongside":[28],"phenotypic":[31],"drug":[32],"assays":[34],"alter":[36],"PI":[37,63,94,165,179,203,211,228,256,271,278,288],"comparison":[40],"with":[43,56,125,218],"a":[44,48,66,128],"wild-type":[45],"Gag.":[46],"Using":[47],"single":[49],"replication-cycle":[50],"assay":[51],"encompassing":[52],"full-length":[53],"together":[55],"protease,":[57],"we":[58],"demonstrate":[59],"significant":[60,121,225],"variation":[61,122,177,226],"between":[65],"number":[67],"PI-na\u00efve":[69],"subtype":[70,76],"B":[71,77],"viruses.":[72],"Six":[73],"publicly":[74],"available":[75],"molecular":[78,98,137],"clones,":[79,99,138],"namely":[80],"HXB2,":[81],"NL4-3,":[82],"SF2,":[83],"YU2,":[84],"JRFL":[85],"and":[86,101,113,155,198,213,234,247,267],"89.6,":[87],"displayed":[88],"up":[89,126],"9-fold":[91],"reduction":[92,109,130,163],"susceptibility.":[95,111,147,257,272],"For":[96],"two":[97],"YU2":[100],"JRFL,":[102],"contributed":[104],"solely":[105],"observed":[108],"from":[115],"treatment-na\u00efve,":[116],"patient-derived":[117],"viruses":[118,233],"also":[119,259],"demonstrated":[120],"susceptibility,":[124,166],"17-fold":[129],"atazanavir.":[132],"In":[133,208],"contrast":[134],"was":[140,186,196],"main":[142],"determinant":[143],"reduced":[146,202,210,277],"Common":[148],"polymorphisms":[149],"including":[152],"I13V,":[153],"L63P":[154],"A71T":[156],"were":[157,216],"contribute":[160,283],"this":[162],"major":[171],"mutations.":[173],"The":[174,188],"role":[175,241],"on":[181,287],"LPV/r":[182],"monotherapy":[183],"treatment":[184,194,206,220,285],"failure":[185,195,286],"investigated.":[187],"contribution":[189],"suboptimal":[191],"adherence":[192],"development":[200],"during":[205],"observed.":[207],"addition,":[209],"single-round":[214],"infectivity":[215],"associated":[217],"subsequent":[219],"failure.":[221],"This":[222],"study":[223],"demonstrates":[224],"treatment-na\u00efve":[231],"patient":[232],"provides":[235],"further":[236],"evidence":[237],"independent":[240],"Gag,":[243],"substrate,":[246],"particular":[249],"amino":[251],"terminus":[252],"It":[258],"highlights":[260],"importance":[262],"considering":[264],"when":[269],"assessing":[270],"These":[273],"data":[274],"indicate":[275],"at":[280],"baseline":[281],"may":[282],"monotherapy.":[289]},"counts_by_year":[],"updated_date":"2026-09-09T07:26:56.047234","created_date":"2016-06-24T00:00:00"}